Novo Nordisk Prepares for July 1 CMS Bridge Program Expanding Wegovy Medicare Access
Novo Nordisk is preparing for the July 1 rollout of the CMS bridge program, which will expand Medicare beneficiaries' access to obesity treatments including Wegovy. US Operations EVP Jamey Millar said the company is uncertain whether patient volume will surge immediately or grow gradually. Efforts are ongoing to educate healthcare providers and pharmacists on patient eligibility criteria.
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!